Have We Underestimated the Importance of Fluid Balance for the Survival of Pd Patients?

Scribner B.H. , Buri R. , Caner J.E.Z. , Hegstrom R. , Burnell J.M. The treatment of chronic uremia by means of intermittent dialysis: a preliminary report. ASAIO Trans 1960; 6: 114–22.

Teehan B.P. , Schleifer C.R. , Brown J.M. , Sigler M.H. , Raimondo J. Urea kinetic analysis and clinical outcome on CAPD. A 5 year longitudinal study. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6: 181–5.

Brandes J.C. , Piering W.F. , Beres J.A. , Blumenthal S.S. , Fritsche C. Clinical outcome of continuous peritoneal dialysis predicted by urea and creatinine kinetics. J Am Soc Nephrol 1992; 2: 1430–5.

Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198–207.

Nolph K.D. , Jensen R.A. , Khanna R. , Twardowski Z.J. Weight limitations for weekly urea clearances using various exchange volumes in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994; 14: 261–4.

Blake P. , Burkart J.M. , Churchill D.N. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16: 448–56.

Raine A.E.G. , Margreiter R. , Brunner F.P. Report on management of renal failure in Europe XXII, 1991. Nephrol Dial Transplant 1992; 7(Suppl 2): 7–35.

Heaf J. CAPD adequacy and dialysis morbidity: detrimental effect of a high peritoneal equilibration rate. Ren Fail 1995; 17: 575–87.

Churchill D.N. , Thorpe K.E. , Nolph K.D. , Oreopoulos D.G. , Page D. , Keshaviah P.R. for the Canada USA (CANUSA) Peritoneal Dialysis Study Group. CAPD patient and technique survivals are worse with increased membrane permeability (Abstract). Perit Dial Int 1996; 16(Suppl 2): S21.

Davies S.J. , Philipps L. , Russell G.I. Peritoneal solute transfer is an independent predictor of survival on CAPD (Abstract). J Am Soc Nephrol 1996; 7:1443.

Wang T. , Heimbürger O. , Waniewski J. , Bergström J. , Lindholm B. Increased peritoneal permeability in CAPD results in decreased fluid and small solute removal and lower survival (Abstract). J Am Soc Nephrol 1996; 7: 1468.

Fried L. PET test and survival. Perit Dial Int 1997; 17(Suppl 1): S60.

Blake P.G. , Flowerdew G. , Blake R.M. , Oreopoulos D.G. Serum albumin in patients on continuous ambulatory peritoneal dialysis -predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3: 1501–7.

Harty J.C. , Boulton H. , Venning M.C. , Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996; 22: 97–101.

Kaysen G.A. , Schoenfeld P.Y. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 107–14.

Davies S.J. , Philipps L. , Bryan J. , Russell G.I. Longitudinal changes in KTN, peritoneal function, protein losses and plasma albumin over 5 years CAPD and their relationship to clinical outcome/patient survival (Abstract). Perit Dial Int 1995; 15: (4)(Suppl): S26.

Scribner B.H. Foreward In: Gokal R. , Nolph K.D. , eds. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic. 1994: VII-VIII.

Rottembourg J. Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 1993; 43(Suppl 40): S106–10.

Wong K-C , Xiong D-W , Kerr P.G. KtN in CAPD by different estimations of V. Kidney Int 1995; 48: 563–9.

Tzamaloukas A.H. , Saddler M.C. , Murata G.H. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am SocNephrol 1995; 6: 198–206.

Canziani M.E. , Cendoroglo Neto M. , Saragoça M.A. Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart. Artif Organs 1995; 19: 241–4.

Saldanha L.F. , Weiler E.W. , Gonick H.C. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993; 21: 184–8.

Faller B. , Lameire N. Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 1994; 9: 280–6.

Cheigh J.S. , Serur D. , Paguirigan M. , Stenzel K.H. , Rubin A. How well is hypertension controlled in CAPD patients? In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10: 55–8.

Velasquez M.T. , Lew S.Q. , von Albertini B. , Miskin G.J. , Bosch J.P. Hypertension control is better during hemodialysis (HD) than during continuous ambulatory peritoneal dialysis (CAPD) in ESRD patients (Abstract). J Am Soc Nephrol 1996; 7: 1468.

Parfrey P.S. , Harnett J.D. , Griffiths S.M. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 1990; 55: 114–20.

Levin A. , Singer J. , Thompson C.R. , Ross H. , Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347–54.

Leenen F.H.H. , Smith D.L. , Khanna K. , Oreopoulos D.G. Changes in left ventricular hypertrophy and function in hypertensive patients started on continuous ambulatory peritoneal dialysis AmHeart J 1985; 110: 102–6.

Lameire N. Cardiovascular risk factors and blood pressure control in continous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13(Suppl 2): S394–5.

Silberberg J.S. , Barre P.E. , Prichard S.S. , Sniderman A.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286–90.

Eisenberg M. , Prichard S. , Barrép , Patton R. , Hutchinson T. , Sniderman A. Left ventricular hypertrophy in endstage renal disease on peritoneal dialysis Am J Cardiol 1987; 60: 418–19.

Hüting J. , Alpert M.A. Progression of left venticular hypertrophy in end-stage renal disease treated by continuous ambulatory peritoneal dialysis depends on hypertension and hypercirculation. Clin Cardiol 1992; 15: 190–6.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barré P.E. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49: 1379–85.

Harnett J.D. , Kent G.M. , Barré P.E. , Taylor R. , Parfrey P.S. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 1994; 4: 1486–90.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barré P.E. The impact of anemia on cardiomyopathy, morbidity and mortality in end stage renal diseases. Am J Kidney Dis 1996; 28: 53–61.

Macdougall I.C. , Lewis N.P. , Saunders M.J. Longterm cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet 1990; 335: 489–93.

Parfrey P.S. , Foley R.N. , Harnett J.D. , Kent G.M. , Murray D. , Barré P.E. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996; 49: 1428–34.

Fernandez J.M. , Carbonell M.E. , Mazzuchi N. , Petruccelli D. Simultaneous analysis of morbidity and mortality factors in chronic hemodialysis patients. Kidney Int 1992; 41: 1029–34.

Charra B. , Calemard E. , Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996; 16: 35–44.

Buoncristiani U. , Gamberi G. , Misuri S. , Carobi C. , Giombini L. , di Paolo N. Diastolic left ventricular malfunction in CAPD patients. In: Ota K. , Maher J.F. , Wichester J.F. , Hirzel P. , eds. Current concepts in peritoneal dialysis. Amsterdam: Elsevier, 1993: 681–6.

Hüting J. , Kramer W. , Reitinger J. , Kühn K. , Schütterle G. , Wizemann V. Abnormal diastolic left ventricular filling by pulsed Doppler echocardiography in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1991; 36: 21–8.

Hüting J. , Schütterle G. Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysis. Am J Cardiol 1992; 69: 123–7.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barré P.E. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995; 5: 2024–31.

Foley R.N. , Parfrey P.S. , Harnett J.D. , Kent G.M. , Murray D.C. , Barré P.E. Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996; 7: 728–36.

Golf S. , Lunde P. , Abrahamsen A.M. , Oyri A. Effect of hydration state on cardiac function in patients on chronic haemodialysis. Br Heart J 1983; 49: 183–6.

Wizemann V. , Kramer W. Short-term dialysis -long term complications. Blood Purif 1987; 5: 193–201.

Mailloux L.U. More dialysis leads to better survival: a point of view. Semin Dial 1992; 5: 224–26.

Dorhout Mees E.J. Volaemia and blood pressure in renal failure: have old truths been forgotten? Nephrol Dial Transplant 1995; 10: 1297–8.

Dorhout Mees E.J. , Özbasli Ç , Akçiçek F. Cardiovascular disturbances in hemodialysis patients: the importance of volume overload. J Nephrol 1995; 8: 71–8.

Cannella G. , Paoletti E. , Delfino R. , Peloso G. , Molinari S. , Traverso G.B. Regression of left ventricular hypertrophy in hypertensive dialysed uremic patients on long-term anti-hypertensive therapy. Kidney Int 1993; 44: 881–6.

Vertes V. , Cangiano J.L. , Berman L.B. , Gould A. Hypertension in end-stage renal disease. N Engl J Med 1969; 18: 978–81.

Charra B. , Laurent G. , Chazot C. Clinical assessment of dry weight. Nephrol Dial Transplant 1996; 11(Suppl 2): 16–19.

Bald M. , Bonzel K.E. , Rascher W. Atrial natriuretic peptide and cyclic guanosine-monophosphate in children and adolescents on peritoneal dialysis. Clin Nephrol 1994; 42: 50–3.

Lauster F. , Heim J.M. , Drummer C. , Fulle H.J. , Gerzer R. , Schiffl H. Plasma cGMP as a marker of the hydration state in renal replacement therapy. Kidney Int 1993; 43(Suppl 41): S57–9.

Mistry C.D. , Gokal R. , Peers E. and the MIDAS Study Group. A randomized multicentre clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutes in CAPD. Kidney Int 1994; 46: 496–503.

Peers E.M. , Scrimgeor A.C. Icodextrin can prolong technique survival in CAPD patients with ultrafiltration failure (Abstract). J Am Soc Nephrol 1995; 6: 513.

Monquil M.C.J. , Imholz A.L.T. , Struijk D.G. , Krediet R.T. Does impaired trans cellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 1995; 15: 42–8.

Ho-dac-Pannekeet M.M. , Struijk D.G. , Krediet R.T. Improvement of trans cellular water transport by treatment with glucose-free dialysate in patients with ultrafiltration failure. Nephrol Dial Transplant 1996; 11: A255.

Imholz AL T. , Koomeng C.M. , Struijk D.G. , Arisz L. , Krediet R.T. Fluid and solute transport in CAPD patients using ultra low sodium dialysate. Kidney Int 1994; 46: 333–40.

Leypoldt J.K. , Charney D.I. , Cheung A.K. , Naprestek C.L. , Akin B.H. , Shockley T.R. Ultrafiltration and solute kinetics using low sodium peritoneal dialysate. Kidney Int 1995; 48:1959–66.

Nakayama M. , Yokoyama K. , Kubo H. The effect of ultra low sodium dialysate in CAPD. A kinetic and clinical analysis. Clin Nephrol 1996; 45: 188–93.

Nakayama M. , Kawaguchi Y. , Yokoyama K. Anti-hypertensive effect of low N a concentration (120 mEq/L) solution for CAPD patients. Clin Nephrol 1994; 4: 357–63.

Yamamoto T. , Sakakura T. , Yamakawa M. Clinical effect of long-term use of neutralised dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992; 60: 324–9.

Feriani M. , Passlick Deetjen J. , Brown C. An open controlled randomized clinical trial with bicarbonate CAPD solutions: interim results (Abstract). J Am Sac Nephrol 1994; 5: 414.

Coles G.A. Are solutions presently used bio-incompatible? Perit Dial Int 1995; 15: (7)(Suppl): S109–14.